Results 1 to 10 of about 248,012 (169)

Ivermectin compared with placebo in the clinical course in Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trial

open access: yesBMC Infectious Diseases, 2022
Background Despite the development and application of vaccines against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) around the world, the scientific community is still trying to find some therapies to avoid or ameliorate the fatal ...
Carmen de la Rocha   +20 more
doaj   +1 more source

Avaliação da eficácia in vitro do Amitraz, Cipermetrina e Ivermectina sobre Bovicola ovis (Schrank, 1781)

open access: yesRevista de Ciências Agroveterinárias, 2023
As doenças parasitárias causadas por piolhos resistentes aos fármacos são causadoras de declínio na produtividade dos rebanhos ovinos no Nordeste do Brasil. Objetivou-se avaliar a eficácia “in vitro” de Amitraz 12,5%, Cipermetrina 15% e Ivermectina 0,5 %
Vanessa Maria de Sales Duarte   +12 more
doaj   +1 more source

Symposium 9: Beyond lifestyle changes. Pharmacological approach

open access: yesRevista de la Sociedad Argentina de Diabetes, 2022
The prevalence of overweight and obesity in pediatrics has increased drastically in recent decades. This leads to a greater cardiometabolic, oncological, psychiatric burden and in the quality of life in adulthood.
Lidia Caracotche
doaj   +1 more source

Symposium 12: People with type 2 diabetes treated with insulin: evidence to associate non-insulin drugs.

open access: yesRevista de la Sociedad Argentina de Diabetes, 2022
Diabetes is one of the fastest growing diseases all over the world. However, the current therapeutic strategies have not been able to stop neither its progressive course nor its complications. One possible explanation might be that the diabetes diagnosis
Matías Re
doaj   +1 more source

Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants

open access: yesScientific Reports, 2022
The severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) variant Omicron spread more rapid than the other variants of SARS-CoV-2 virus. Mutations on the Spike (S) protein receptor-binding domain (RBD) are critical for the antibody resistance ...
Clauber Henrique Souza da Costa   +3 more
doaj   +1 more source

Psychopharmacological effects of riparin III from Aniba riparia (Nees) Mez. (Lauraceae) supported by metabolic approach and multivariate data analysis

open access: yesBMC Complementary Medicine and Therapies, 2020
Background Currently there is a high prevalence of humor disorders such as anxiety and depression throughout the world, especially concerning advanced age patients. Aniba riparia (Nees) Mez.
Sócrates Golzio dos Santos   +9 more
doaj   +1 more source

Synthesis and antimycobacterial evaluation of new gem- difluorohydrazides

open access: yesOrbital: The Electronic Journal of Chemistry, 2012
Several gem-difluorohydrazides were prepared by the addition of nitrogen nucleophiles to N-acetyl-2,2-gem-difluoroxindoles substituted in position 5. Initially, commercial isatin was N-acetylated using acetic anhydride.
Frederico S. C. Branco   +4 more
doaj   +1 more source

A brief overview of current drug repurposing approaches for COVID-19 management [PDF]

open access: yes, 2020
This brief overview is intended to shed light on the current drug repositioning (also called drug repurposing) in the therapeutics of the novel coronavirus disease which emerged in 2019 (COVID-19).
Rodrigues, Pedro da Fonseca Soares   +1 more
core   +2 more sources

Spectroscopic and Theoretical Study of CuI Binding to His111 in the Human Prion Protein Fragment 106-115 [PDF]

open access: yes, 2016
The ability of the cellular prion protein (PrPC) to bind copper in vivo points to a physiological role for PrPC in copper transport. Six copper binding sites have been identified in the nonstructured N-terminal region of human PrPC.
Alberto Vela   +12 more
core   +2 more sources

Synthesis, Biological Evaluation, and Molecular Modeling Studies of New Thiadiazole Derivatives as Potent P2X7 Receptor Inhibitors

open access: yesFrontiers in Chemistry, 2019
Twenty new 2-(1H-pyrazol-1-yl)-1,3,4-thiadiazole analogs were synthetized to develop P2X7 receptor (P2X7R) inhibitors. P2X7R inhibition in vitro was evaluated in mouse peritoneal macrophages, HEK-293 cells transfected with hP2X7R (dye uptake assay), and ...
Daniel T. G. Gonzaga   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy